-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q4Xh1tjHQLkdpThhmau+u/zUvZ/kaA9Q0Xgf5cNzTSD/KBaRjtm6Q0lbzcWKJOGq BDvSlNkuRBbOh3dGq/4InA== /in/edgar/work/0001012870-00-005939/0001012870-00-005939.txt : 20001122 0001012870-00-005939.hdr.sgml : 20001122 ACCESSION NUMBER: 0001012870-00-005939 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RITA MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0001056421 STANDARD INDUSTRIAL CLASSIFICATION: [3845 ] IRS NUMBER: 943199149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: SEC FILE NUMBER: 333-36160 FILM NUMBER: 774331 BUSINESS ADDRESS: STREET 1: 967 N SHORELINE BLVD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94013 BUSINESS PHONE: 6503858500 MAIL ADDRESS: STREET 1: 967 NORTH SHORELINE BLVD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 POS AM 1 0001.txt POST EFFECTIVE AMENDMENT NO.1 TO FORM S-1 As filed with the Securities and Exchange Commission on November 21, 2000 Registration No. 333-36160 - ------------------------------------------------------------------------------- - ------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------ POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-1 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 ------------ RITA MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 3845 94-3199149 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.)
967 N. Shoreline Blvd. Mountain View, CA 94043 (650) 390-8500 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ------------ Barry N. Cheskin Chief Executive Officer RITA Medical Systems, Inc. 967 N. Shoreline Blvd. Mountain View, CA 94043 (650) 390-8500 (Name, address, including zip code, and telephone number, including area code, of agent for service) ------------ Copies to: Mark B. Weeks John W. White Brooke Campbell CRAVATH, SWAINE & MOORE Ughetta Manzone Worldwide Plaza VENTURE LAW GROUP 825 Eighth Avenue A Professional Corporation New York, New York 10019 2800 Sand Hill Road Menlo Park, California 94025
------------ Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. [_] If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [_] If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [_] If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [_] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [_] ------------ The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. - ------------------------------------------------------------------------------- - ------------------------------------------------------------------------------- Explanatory Note The Registrant had registered 3,400,000 shares of common stock, including 510,000 shares of common stock issuable upon exercise of the Underwriters' over-allotment option. Of that over-allotment option, 510,000 shares of common stock were not sold and are being removed from registration. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this amended registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Menlo Park, State of California, on November 21, 2000. RITA MEDICAL SYSTEMS, INC. /s/ Barry Cheskin By: _________________________________ Barry Cheskin President and Chief Executive Officer Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
Signature Title Date --------- ----- ---- /s/ Barry Cheskin President, Chief November 21, 2000 ___________________________________ Executive Officer Barry Cheskin and Director /s/ Marilynne Solloway Chief Financial Officer November 21, 2000 ___________________________________ Marilynne Solloway * Director November 21, 2000 ___________________________________ Gordon Russell * Director November 21, 2000 ___________________________________ Scott Halsted * Director November 21, 2000 ___________________________________ Janet Effland * Director November 21, 2000 ___________________________________ Vincent Bucci * Director November 21, 2000 ___________________________________ John Gilbert
* Power of attorney. /s/ Marilynne Solloway *By____________________________ Marilynne Solloway Attorney-in-Fact -----END PRIVACY-ENHANCED MESSAGE-----